default author photo

Reinhard Buettner

University of Cologne

Albertus-Magnus-Platz

Cologne, 50923

Germany

SCHOLARLY PAPERS

5

DOWNLOADS

233

TOTAL CITATIONS

0

Scholarly Papers (5)

1.

Efficiency of B-RAF-/MEK-Inhibitors in B-RAF Mutated Ameloblastoma: Case Report and Review of Literature

Number of pages: 22 Posted: 06 Jan 2023
University of Cologne, Gazi University, University of Cologne - University Hospital of Cologne, University of Cologne - University Hospital of Cologne, University of Cologne - University Hospital of Cologne and University of Cologne - University Hospital of Cologne
Downloads 118 (608,822)

Abstract:

Loading...

Ameloblastoma, B-RAF-/MEK-inhibitors, Neoadjuvant therapy

2.

Evaluating Docetaxel Effectiveness in Kras G12c-Mutated Nsclc: Insights from a Real-World Cohort

Number of pages: 20 Posted: 09 Jun 2025
University of Cologne - Department I of Internal Medicine, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Cologne - Institute of Diagnostic and Interventional Radiology, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Cologne, affiliation not provided to SSRN, University of Cologne, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Cologne, University of Cologne, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 43 (1,145,425)

Abstract:

Loading...

NSCLC - Real-world-data - KRAS G12C mutation - docetaxel treatment - molecular analyses

3.

Follicular Cholangitis of the Liver Masking Langerhans Cell Histiocytosis

Number of pages: 34 Posted: 30 Jan 2026
affiliation not provided to SSRN, University of Cologne, DRK Kliniken Berlin, DRK Kliniken Berlin and affiliation not provided to SSRN
Downloads 26 (1,411,822)

Abstract:

Loading...

Follicular cholangitis - Langerhans cell histiocytosis of the liver - Innate immune system - Bile duct stenosis - Liver fibrosis

4.

UBQLN1-Mediated Repression of Homologous Recombination is an Actionable Target for Cancer Therapy

Number of pages: 86 Posted: 01 Apr 2026
Max Planck Institute for Biology of Ageing, Max Planck Institute for Biology of Ageing, Max Planck Institute for Biology of Ageing, Max Planck Institute for Biology of Ageing, University of Cologne, University of Seville, University of Seville, Max Planck Institute for Biology of Ageing, Max Planck Institute for Biology of Ageing, Max Planck Institute for Biology of Ageing, Max Planck Institute for Biology of Ageing, Max Planck Institute for Biology of Ageing, Max Planck Institute for Biology of Ageing, Max Planck Institute for Biology of Ageing, Max Planck Institute for Biology of Ageing, University of Cologne, Max Planck Institute for Biology of Ageing, Max Planck Institute for Biology of Ageing, University of Cologne, University of Cologne, Max Planck Institute for Biology of Ageing, Providence Saint John's Health Center (SJHC), University of Duisburg-Essen - University Hospital Essen, Max Planck Institute for Biochemistry, University of Cologne, Max Planck Institute for Biology of Ageing, Max Planck Institute for Metabolism Research, Max Planck Institute for Biology of Ageing, University of Cologne - University Hospital of Cologne, Tel Aviv University, Providence Saint John's Health Center (SJHC), University of Cologne, University of Cologne, University of Cologne, Zeynep Kamil Maternity and Children's Training and Research Hospital, Baylor College of Medicine, Baylor College of Medicine, University of Cologne, Max Planck Institute for Biology of Ageing, University of Seville, Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf, University of Cologne, University of Cologne, Saint John’s Cancer Institute at Providence Saint John’s Health Center, University of Cologne, Heinrich Heine University Dusseldorf, Department of Hematology and Stem Cell Transplantation, University of Duisburg-Essen and Max Planck Institute for Biology of Ageing
Downloads 24 (1,436,435)

Abstract:

Loading...

DNA damage, DNA double-strand break repair, Homologous recombination, cancer, targeted cancer therapy, UBQLN1 deficiency syndrome, UBQLN1, RAD51, MRE11, genome instability, syndrome, Ubiquitin, proteasomal degradation, Lung Cancer, PARP, ICB

5.

Congenital portosystemic shunt (CPSS) / Abernethy malformation: Functional pathology and molecular aspects of a hepatic tumour risk disease

Number of pages: 46 Posted: 18 Mar 2026
affiliation not provided to SSRN, University of Cologne, University of Cologne - University Hospital of Cologne, affiliation not provided to SSRN, University of Cologne and affiliation not provided to SSRN
Downloads 22 (1,491,251)

Abstract:

Loading...

Congenital portosystemic shunt, HCC carcinogenesis, β-catenin, glutamine synthetase, ammonia metabolism, liver zonation